Want to join the conversation?
Biopharmaceutical company $BXLT said it presented data on the usage of ADYNOVATE in the treatment of patients with hemophilia A at the 57th American Society of Hematology (ASH) Annual Meeting. ADYNOVATE is a human antihemophilic factor indicated for treatment and control of bleeding episodes and to reduce frequency of bleeding episodes.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.